Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2006; 12(15): 2417-2422
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2417
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2417
Table 2 Histological findings in 13 patients with biopsy performed [median (range)]
| Baseline biopsy | End of treatment biopsy | |||
| Virological end-treat- ment response | Necroinflammatory | Fibrosis | Necroinflammatory | Fibrosis |
| activity | activity | |||
| None (n = 8) | 3 | 2 | 2 | 3 |
| (1-3) | (1-3) | (1-4) | (1-4) | |
| Partial (n = 2) | 2.5 | 2.5 | 2.5 | 2.5 |
| (2-3) | (2-3) | (2-3) | (2-3) | |
| Complete (n = 3) | 2 | 2 | 1 | 1 |
| (2-3) | (2-2) | (1-2) | (1-2) | |
- Citation: Vassiliadis T, Patsiaoura K, Tziomalos K, Gkiourtzis T, Giouleme O, Grammatikos N, Rizopoulou D, Nikolaidis N, Katsinelos P, Orfanou-Koumerkeridou E, Eugenidis N. Pegylated IFN-α 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B. World J Gastroenterol 2006; 12(15): 2417-2422
- URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2417.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2417